Genes & Cancer · 2015 · 30 citations · 20 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyChemotherapyTargeted Cancer TherapyTumor-activated ProdrugsAnimal Disease ModelsCancer Cell Survival SignalingCell Survival AssaysHeat Shock Protein InhibitorsPhosphatase-activated ProdrugsSolubilityTumor-targeted ProdrugsXenograft Survival
Malignant mesothelioma is a devastating disease with a poor prognosis for which there is a clear need for more successful therapeutic approaches. Triptolide, a diterpenoid triepoxide, is a highly effective agent against several cancer types in animal models. Owing to triptolide's poor solubility in water, a water-soluble analog, minnelide, was synthesized. Minnelide is a prodrug of triptolide and is activated by exposure to phosphatases that are found in all body tissues, including blood. Mesothelioma cells were treated in vitro with minnelide or its parent compound, triptolide. Minnelide and triptolide were both found to significantly reduce mesothelioma cell viability and induce apoptosis. The level of Hsp70, a protein that promotes cancer cell survival, was measured in mesothelioma cells before and after treatment with triptolide. Hsp70 levels were decreased in a dose-dependent manner. In addition, triptolide sensitized cells to gemcitabine and pemetrexed as measured by cell viability. Mice bearing mesothelioma flank tumors were treated with daily injections (28 d) of minnelide or saline solution and xenograft tumor growth recorded. Mice displayed significantly reduced tumor burden. These findings support the clinical evaluation of minnelide therapy for mesothelioma.
20
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Denis V. Titov, Benjamin Gilman, Qingli He et al. · Nature Chemical Biology · 2011 · 522 citations · Full text
Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70
Phoebe A. Phillips, Vikas Dudeja, Joshua A. McCarroll et al. · Cancer Research · 2007 · 307 citations
Medicine, Oncology, Pharmacology +17